LAVA Therapeutics NVNASDAQ:LVTX
No Matches were found for
- LAST PRICE2.2600
- TODAY'S CHANGE (%)-0.1400 (-5.8333%)
- Bid / Lots2.2600/ 1
- Ask / Lots2.5000/ 30
- Open / Previous Close2.3600 / 2.4000
- Day Range
- 52 Week Range
- Volume210,942
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LVTX |
|---|---|---|
| 09:32 ET | 1272 | 2.36 |
| 09:39 ET | 400 | 2.36 |
| 09:41 ET | 400 | 2.36 |
| 09:43 ET | 800 | 2.36 |
| 09:45 ET | 800 | 2.37 |
| 09:48 ET | 400 | 2.37 |
| 09:50 ET | 400 | 2.37 |
| 09:52 ET | 765 | 2.36 |
| 09:54 ET | 4962 | 2.37 |
| 09:56 ET | 100 | 2.37 |
| 09:57 ET | 4110 | 2.37 |
| 10:14 ET | 5370 | 2.38 |
| 10:15 ET | 100 | 2.38 |
| 10:17 ET | 100 | 2.38 |
| 10:19 ET | 2950 | 2.38 |
| 10:21 ET | 1600 | 2.38 |
| 10:35 ET | 2214 | 2.431 |
| 10:37 ET | 705 | 2.36 |
| 10:42 ET | 800 | 2.36 |
| 10:46 ET | 1000 | 2.37 |
| 10:48 ET | 400 | 2.37 |
| 10:50 ET | 400 | 2.37 |
| 10:51 ET | 400 | 2.37 |
| 10:55 ET | 650 | 2.36 |
| 11:00 ET | 800 | 2.355 |
| 11:04 ET | 1143 | 2.355 |
| 11:06 ET | 200 | 2.355 |
| 11:08 ET | 400 | 2.355 |
| 11:09 ET | 2300 | 2.385 |
| 11:11 ET | 700 | 2.355 |
| 11:13 ET | 400 | 2.355 |
| 11:15 ET | 2300 | 2.355 |
| 11:18 ET | 900 | 2.3425 |
| 11:20 ET | 287 | 2.34 |
| 11:22 ET | 400 | 2.35 |
| 11:24 ET | 2313 | 2.3475 |
| 11:26 ET | 500 | 2.34 |
| 11:27 ET | 400 | 2.33 |
| 11:29 ET | 2295 | 2.33 |
| 11:31 ET | 400 | 2.32 |
| 11:33 ET | 7115 | 2.32 |
| 11:36 ET | 200 | 2.32 |
| 11:38 ET | 2200 | 2.32 |
| 11:40 ET | 8745 | 2.32 |
| 11:42 ET | 2126 | 2.35 |
| 11:44 ET | 2474 | 2.35 |
| 11:45 ET | 200 | 2.37 |
| 11:54 ET | 1500 | 2.36 |
| 11:56 ET | 800 | 2.36 |
| 12:09 ET | 400 | 2.34 |
| 12:12 ET | 4960 | 2.33 |
| 12:14 ET | 4749 | 2.32 |
| 12:16 ET | 200 | 2.32 |
| 12:18 ET | 400 | 2.32 |
| 12:20 ET | 200 | 2.32 |
| 12:21 ET | 2119 | 2.32 |
| 12:23 ET | 7171 | 2.3 |
| 12:27 ET | 676 | 2.3 |
| 12:30 ET | 1256 | 2.25 |
| 12:32 ET | 200 | 2.25 |
| 12:34 ET | 3363 | 2.28 |
| 12:39 ET | 400 | 2.33 |
| 12:48 ET | 1600 | 2.32 |
| 12:50 ET | 1125 | 2.31 |
| 12:54 ET | 1200 | 2.305 |
| 12:56 ET | 1300 | 2.29 |
| 12:57 ET | 700 | 2.26 |
| 12:59 ET | 200 | 2.26 |
| 01:01 ET | 200 | 2.26 |
| 01:03 ET | 1400 | 2.26 |
| 01:06 ET | 200 | 2.26 |
| 01:08 ET | 200 | 2.26 |
| 01:10 ET | 2500 | 2.2999 |
| 01:12 ET | 400 | 2.27 |
| 01:14 ET | 200 | 2.285 |
| 01:15 ET | 377 | 2.27 |
| 01:17 ET | 300 | 2.29 |
| 01:19 ET | 200 | 2.26 |
| 01:21 ET | 200 | 2.26 |
| 01:24 ET | 200 | 2.26 |
| 01:26 ET | 400 | 2.26 |
| 01:28 ET | 200 | 2.26 |
| 01:30 ET | 197 | 2.26 |
| 01:32 ET | 1400 | 2.29 |
| 01:33 ET | 200 | 2.26 |
| 01:35 ET | 2191 | 2.27 |
| 01:37 ET | 400 | 2.26 |
| 01:39 ET | 100 | 2.26 |
| 01:42 ET | 500 | 2.265 |
| 01:44 ET | 200 | 2.25 |
| 01:46 ET | 200 | 2.25 |
| 01:48 ET | 200 | 2.25 |
| 01:50 ET | 300 | 2.265 |
| 01:51 ET | 400 | 2.25 |
| 01:53 ET | 400 | 2.25 |
| 01:55 ET | 300 | 2.25 |
| 01:57 ET | 500 | 2.25 |
| 02:00 ET | 400 | 2.25 |
| 02:02 ET | 200 | 2.25 |
| 02:04 ET | 400 | 2.25 |
| 02:06 ET | 393 | 2.25 |
| 02:08 ET | 12586 | 2.26 |
| 02:24 ET | 300 | 2.26 |
| 02:26 ET | 300 | 2.25 |
| 02:27 ET | 300 | 2.25 |
| 02:29 ET | 300 | 2.25 |
| 02:31 ET | 400 | 2.25 |
| 02:33 ET | 300 | 2.25 |
| 02:36 ET | 300 | 2.25 |
| 02:38 ET | 300 | 2.25 |
| 02:40 ET | 300 | 2.25 |
| 02:42 ET | 300 | 2.25 |
| 02:44 ET | 300 | 2.25 |
| 02:45 ET | 300 | 2.25 |
| 02:47 ET | 300 | 2.25 |
| 02:49 ET | 300 | 2.25 |
| 02:54 ET | 600 | 2.25 |
| 02:56 ET | 300 | 2.25 |
| 02:58 ET | 9426 | 2.2988 |
| 03:00 ET | 5880 | 2.375 |
| 03:09 ET | 12300 | 2.41 |
| 03:12 ET | 1500 | 2.44 |
| 03:14 ET | 12877 | 2.39 |
| 03:18 ET | 1016 | 2.38 |
| 03:27 ET | 906 | 2.31 |
| 03:32 ET | 600 | 2.37 |
| 03:34 ET | 700 | 2.25 |
| 03:38 ET | 800 | 2.25 |
| 03:39 ET | 600 | 2.25 |
| 03:41 ET | 600 | 2.25 |
| 03:43 ET | 600 | 2.25 |
| 03:45 ET | 600 | 2.25 |
| 03:48 ET | 1900 | 2.3565 |
| 03:50 ET | 600 | 2.35 |
| 03:52 ET | 400 | 2.31 |
| 03:54 ET | 800 | 2.3 |
| 03:56 ET | 2200 | 2.2543 |
| 03:57 ET | 400 | 2.315 |
| 03:59 ET | 3100 | 2.26 |
May 30, 2024
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference, from 7:00AM ET on Thursday May 30, 2024 by Dow Jones
7:00AM ET on Thursday May 30, 2024 by Dow Jones
May 21, 2024
Press Release: LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results, from 7:00AM ET on Tuesday May 21, 2024 by Dow Jones
7:00AM ET on Tuesday May 21, 2024 by Dow JonesLAVA Provides Business Updates and Reports First Quarter 2024 Financial Results, from 7:00AM ET on Tuesday May 21, 2024 by Dow Jones
7:00AM ET on Tuesday May 21, 2024 by Dow Jones
May 6, 2024
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference, from 4:05PM ET on Monday May 06, 2024 by Dow Jones
4:05PM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LAVA Therapeutics NV | 59.4M | -2.1x | --- |
Kezar Life Sciences Inc | 50.5M | -0.5x | --- |
BioLine RX Ltd | 58.4M | -1.0x | --- |
Kronos Bio Inc | 47.5M | -0.4x | --- |
DURECT Corp | 53.1M | -2.0x | --- |
Atara Biotherapeutics Inc | 67.5M | -0.3x | --- |
Company Information
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Contact Information
- Headquarters
- Yalelaan 60UTRECHT, Netherlands 3584 CM
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Kapil Dhingra
- President, Chief Executive Officer, Management Director
- Stephen Hurly
- Chief Financial Officer
- Edward Smith
- Executive Vice President Head of Research and Development
- Paul Parren
- Chief Scientific Officer
- Hans Van Der Vliet
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $59.4M |
|---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 4.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
